You have 9 free searches left this month | for more free features.

Drug Therapy

Showing 26 - 50 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Glaucoma, Open-Angle Trial in Bochum, Lübeck (Beacon Aqueous Microshunt)

Active, not recruiting
  • Glaucoma, Open-Angle
  • Beacon Aqueous Microshunt
  • Bochum, Germany
  • +1 more
Feb 1, 2022

Drug Resistant Epilepsy Trial in Medan (Cholecalciferol, )

Not yet recruiting
  • Drug Resistant Epilepsy
  • Medan, North Sumatra, Indonesia
    Faculty of Medicine Universitas Sumatera Utara
Sep 21, 2023

Elevated Lipoprotein(a) Level, Coronary Artery Disease, Drug-Eluting Stent Trial in Beijing (24 Months DAPT, 12 Months DAPT)

Not yet recruiting
  • Elevated Lipoprotein(a) Level
  • +3 more
  • 24 Months DAPT
  • 12 Months DAPT
  • Beijing, Beijing, China
    Fuwai Hospital, National Center for Cardiovascular Diseases, Chi
Aug 26, 2023

Schizophrenia and Related Disorders, Drug Administration Schedule, Drug Therapy Trial in Toronto (Risperidone, Olanzapine)

Recruiting
  • Schizophrenia and Related Disorders
  • +3 more
  • Toronto, Ontario, Canada
    Centre for Addiction and Mental Health
Jul 20, 2022

Crohn Disease, Infliximab, Perianal Fistula Due to Crohn's Disease Trial (TDM-based infliximab intravenous therapy, Standard

Not yet recruiting
  • Crohn Disease
  • +4 more
  • TDM-based infliximab intravenous therapy
  • Standard infliximab intravenous therapy
  • (no location specified)
Sep 26, 2023

Urogenital Tumors, Drug Therapy Trial in Campinas (Biopsy)

Completed
  • Urogenital Neoplasms
  • Drug Therapy
  • Biopsy
  • Campinas, SP, Brazil
    Hospital das Clínicas Unicamp
Jul 7, 2022

In-stent Restenosis Trial in Beijing (Colchicine, Prednisone, Aspirin)

Not yet recruiting
  • In-stent Restenosis
  • Beijing, Beijing, China
    Fuwai Hospital
Oct 15, 2023

Opioid-Related Disorders, Drug Abuse Trial (Contingency management, Cognitive-Behavior Therapy Modules, Peer Contingency

Not yet recruiting
  • Opioid-Related Disorders
  • Drug Abuse
  • Contingency management
  • +5 more
  • (no location specified)
Nov 13, 2023

Aplastic Anemia, CSA, Drug Therapy Trial in Beijing (CsA+ATG+Herombopag, CsA+Herombopag)

Recruiting
  • Aplastic Anemia
  • +2 more
  • Beijing, China
    Peking union medical college hospital
Aug 20, 2023

Remaxol® in Drug-induced Liver Injuries During Antitumor Therapy

Recruiting
  • Cancer
  • Drug Induced Liver Injury
  • Krasnoyarsk, Russian Federation
  • +4 more
Mar 16, 2023

Food Allergy Trial (Drug: Chinese Herbal Medication, Drug: Placebo, Drug: Omalizumab)

Completed
  • Food Allergy
  • Drug: Chinese Herbal Medication
  • +2 more
  • (no location specified)
Oct 24, 2023

Vestibular Disorder Preservation Trial in Quetta (Gentamicin, Dexamethasone)

Recruiting
  • Vestibular Disorder Preservation
  • Quetta, Balochistan, Pakistan
    CMH Quetta
Apr 27, 2022

Ischemic Stroke, Vertebral Artery Stenosis Trial in Beijing (Drug-eluting stenting plus aspirin and clopidogrel or ticagrelor,

Not yet recruiting
  • Ischemic Stroke
  • Vertebral Artery Stenosis
  • Drug-eluting stenting plus aspirin and clopidogrel or ticagrelor
  • +2 more
  • Beijing, China
    Xuanwu Hospital, Capital Medical University.
Jun 1, 2023

Acute Coronary Syndrome Trial (rivaroxaban)

Not yet recruiting
  • Acute Coronary Syndrome
  • (no location specified)
Feb 20, 2023

Hypertriglyceridemia, Familial Trial in Nanjing (GC304)

Not yet recruiting
  • Hypertriglyceridemia, Familial
  • GC304
  • Nanjing, China
    Affiliated Jinling Hospital, Medical School, Nanjing University
May 5, 2023

In-stent Restenosis and de Novo Coronary Lesions

Recruiting
  • Coronary Heart Disease
  • Pretreatment strategies before drug balloon therapy
  • Different types of in-stent restenosis were treated with drug-coated balloons
  • Nanjing, Jiangsu, China
    The First Affiliated Hospital of Nanjing Medical University
Oct 24, 2022

Muscle-invasive Bladder Cancer Based on PTC Drug Sensitivity

Recruiting
  • Muscle-Invasive Bladder Carcinoma
  • Patient-derived tumor-like cell clusters (PTC) drug sensitivity testing
  • Beijing, Beijing, China
    Chinese PLA General Hospital
Mar 11, 2023

Squamous Cell Carcinoma of Head and Neck Trial in Hangzhou (Toripalimab)

Recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • Hangzhou, Zhejiang, China
    Department of Medical Onocology, First Affiliated Hospital of Zh
Oct 7, 2023

Monitoring Drug Efficacy in Patients With Alzheimer's Disease

Recruiting
  • Alzheimer Disease
  • AChE inhibitor monotherapy
  • AChE inhibitor and NMDA receptor antagonist combination therapy
  • Manila, Metro Manila, Philippines
    Philippine General Hospital
Mar 24, 2023

Kidney Stones, Nephrolithiasis Trial in Nashville (Empiric Therapy: Diet, Empiric Therapy: Drug, Selective Therapy: Diet)

Recruiting
  • Kidney Stones
  • Nephrolithiasis
  • Empiric Therapy: Diet
  • +3 more
  • Nashville, Tennessee
    Vanderbilt University Medical Center
Jan 23, 2023

Adolescence

Recruiting
  • Epilepsy
  • Treatment Adherence
    • Trieste, Italy
      IRCCS Burlo Garofolo
    Apr 11, 2023

    Low Back Pain Trial in Whittier

    Completed
    • Low Back Pain
      • Whittier, California
        Southern California University of Health Sciences
      Sep 22, 2021

      Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 Trial

      Recruiting
      • Anatomic Stage I Breast Cancer AJCC v8
      • +3 more
      • Best Practice
      • +5 more
      • Ames, Iowa
        Mary Greeley Medical Center
      Jan 24, 2023

      Colo-rectal Cancer Trial in Beijing (adjuvant therapy based on 3D drug sensitivity test results of micro tumor (PTC) in vitro)

      Recruiting
      • Colo-rectal Cancer
      • adjuvant therapy based on 3D drug sensitivity test results of micro tumor (PTC) in vitro
      • Beijing, China/Beijing, China
        Peking Union Medical College Hospital, Chinese Academy of Medici
      Aug 4, 2023

      Rheumatoid Arthritis Trial in Boston (Therapeutic drug monitoring (TDM))

      Not yet recruiting
      • Rheumatoid Arthritis
      • Therapeutic drug monitoring (TDM)
      • Boston, Massachusetts
        Boston Medical Center, Rheumatology Clinic
      Jul 13, 2022